Radiotherapy with or Without Concomitant Temozolomide for Brain Metastases of Non-Small Cell Lung Cancer

Trial Profile

Radiotherapy with or Without Concomitant Temozolomide for Brain Metastases of Non-Small Cell Lung Cancer

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Brain metastases; Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2012 New trial record
    • 29 Sep 2012 Interim results (n=20) presented at the 37th Congress of the European Society for Medical Oncology.
    • 29 Sep 2012 Recruitment is ongoing and to date 20 patients have been included.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top